Phase 1, Open-Label Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

Conditions:   Refractory Non-Hodgkin Lymphoma;   Relapsed Non-Hodgkin Lymphoma Interventions:   Biological: SIRPant-M;   Radiation: External-beam radiotherapy (XRT) Sponsor:   SIRPant Immunotherapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials